Clinical Trial Update: Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating guanfacine as an adjunct to atypical antipsychotics for cognitive dysfunction in schizophrenia and schizoaffective disorder. C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Guanfacine (guanfacine)

Snippet

Sponsor: Research Foundation for Mental Hygiene, Inc. | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: UNKNOWN